[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Multiple System Atrophy Therapeutics Market Report 2017

January 2018 | 103 pages | ID: UA9ADCA6C9AEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Multiple System Atrophy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Multiple System Atrophy Therapeutics in these regions, from 2012 to 2022 (forecast).
United States Multiple System Atrophy Therapeutics market competition by top manufacturers/players, with Multiple System Atrophy Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AFFiRiS AG
  • AstraZeneca Plc
  • Corestem Inc
  • MitoDys Therapeutics Ltd
  • Modag GmbH
  • Neuropore Therapies Inc
  • Prana Biotechnology Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Anle-138b
  • AZD-3241
  • CS-10BR05
  • NPT-20011
  • PBT-434
  • PD-01
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Multiple System Atrophy Therapeutics Market Report 2017

1 MULTIPLE SYSTEM ATROPHY THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Multiple System Atrophy Therapeutics
1.2 Classification of Multiple System Atrophy Therapeutics by Product Category
  1.2.1 United States Multiple System Atrophy Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Multiple System Atrophy Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Anle-138b
  1.2.4 AZD-3241
  1.2.5 CS-10BR05
  1.2.6 NPT-20011
  1.2.7 PBT-434
  1.2.8 PD-01
1.3 United States Multiple System Atrophy Therapeutics Market by Application/End Users
  1.3.1 United States Multiple System Atrophy Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Multiple System Atrophy Therapeutics Market by Region
  1.4.1 United States Multiple System Atrophy Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Multiple System Atrophy Therapeutics Status and Prospect (2012-2022)
  1.4.3 Southwest Multiple System Atrophy Therapeutics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Multiple System Atrophy Therapeutics Status and Prospect (2012-2022)
  1.4.5 New England Multiple System Atrophy Therapeutics Status and Prospect (2012-2022)
  1.4.6 The South Multiple System Atrophy Therapeutics Status and Prospect (2012-2022)
  1.4.7 The Midwest Multiple System Atrophy Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Multiple System Atrophy Therapeutics (2012-2022)
  1.5.1 United States Multiple System Atrophy Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 United States Multiple System Atrophy Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES MULTIPLE SYSTEM ATROPHY THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Multiple System Atrophy Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Multiple System Atrophy Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Multiple System Atrophy Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Multiple System Atrophy Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Multiple System Atrophy Therapeutics Market Concentration Rate
  2.4.2 United States Multiple System Atrophy Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Multiple System Atrophy Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MULTIPLE SYSTEM ATROPHY THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Multiple System Atrophy Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Multiple System Atrophy Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Multiple System Atrophy Therapeutics Price by Region (2012-2017)

4 UNITED STATES MULTIPLE SYSTEM ATROPHY THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Multiple System Atrophy Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Multiple System Atrophy Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Multiple System Atrophy Therapeutics Price by Type (2012-2017)
4.4 United States Multiple System Atrophy Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES MULTIPLE SYSTEM ATROPHY THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Multiple System Atrophy Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Multiple System Atrophy Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES MULTIPLE SYSTEM ATROPHY THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AFFiRiS AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Multiple System Atrophy Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AFFiRiS AG Multiple System Atrophy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca Plc
  6.2.2 Multiple System Atrophy Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Plc Multiple System Atrophy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Corestem Inc
  6.3.2 Multiple System Atrophy Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Corestem Inc Multiple System Atrophy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 MitoDys Therapeutics Ltd
  6.4.2 Multiple System Atrophy Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Modag GmbH
  6.5.2 Multiple System Atrophy Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Modag GmbH Multiple System Atrophy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Neuropore Therapies Inc
  6.6.2 Multiple System Atrophy Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Neuropore Therapies Inc Multiple System Atrophy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Prana Biotechnology Ltd
  6.7.2 Multiple System Atrophy Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 MULTIPLE SYSTEM ATROPHY THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Multiple System Atrophy Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Multiple System Atrophy Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Multiple System Atrophy Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Multiple System Atrophy Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MULTIPLE SYSTEM ATROPHY THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Multiple System Atrophy Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Multiple System Atrophy Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Multiple System Atrophy Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Multiple System Atrophy Therapeutics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Multiple System Atrophy Therapeutics
Figure United States Multiple System Atrophy Therapeutics Market Size (K Pcs) by Type (2012-2022)
Figure United States Multiple System Atrophy Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Anle-138b Product Picture
Figure AZD-3241 Product Picture
Figure CS-10BR05 Product Picture
Figure NPT-20011 Product Picture
Figure PBT-434 Product Picture
Figure PD-01 Product Picture
Figure United States Multiple System Atrophy Therapeutics Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Multiple System Atrophy Therapeutics by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Multiple System Atrophy Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Multiple System Atrophy Therapeutics Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Multiple System Atrophy Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Multiple System Atrophy Therapeutics Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Multiple System Atrophy Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Multiple System Atrophy Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Multiple System Atrophy Therapeutics Sales Share by Players/Suppliers
Figure United States Multiple System Atrophy Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Multiple System Atrophy Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Multiple System Atrophy Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Multiple System Atrophy Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Multiple System Atrophy Therapeutics Revenue Share by Players/Suppliers
Table United States Market Multiple System Atrophy Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Multiple System Atrophy Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Multiple System Atrophy Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Multiple System Atrophy Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Multiple System Atrophy Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Multiple System Atrophy Therapeutics Product Category
Table United States Multiple System Atrophy Therapeutics Sales (K Pcs) by Region (2012-2017)
Table United States Multiple System Atrophy Therapeutics Sales Share by Region (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Share by Region (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Market Share by Region in 2016
Table United States Multiple System Atrophy Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Multiple System Atrophy Therapeutics Revenue Share by Region (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Revenue Market Share by Region in 2016
Table United States Multiple System Atrophy Therapeutics Price (USD/Pcs) by Region (2012-2017)
Table United States Multiple System Atrophy Therapeutics Sales (K Pcs) by Type (2012-2017)
Table United States Multiple System Atrophy Therapeutics Sales Share by Type (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Share by Type (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Market Share by Type in 2016
Table United States Multiple System Atrophy Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Multiple System Atrophy Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Multiple System Atrophy Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Multiple System Atrophy Therapeutics by Type in 2016
Table United States Multiple System Atrophy Therapeutics Price (USD/Pcs) by Types (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Multiple System Atrophy Therapeutics Sales (K Pcs) by Application (2012-2017)
Table United States Multiple System Atrophy Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Market Share by Application in 2016
Table United States Multiple System Atrophy Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Multiple System Atrophy Therapeutics Sales Growth Rate by Application (2012-2017)
Table AFFiRiS AG Basic Information List
Table AFFiRiS AG Multiple System Atrophy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AFFiRiS AG Multiple System Atrophy Therapeutics Sales Growth Rate (2012-2017)
Figure AFFiRiS AG Multiple System Atrophy Therapeutics Sales Market Share in United States (2012-2017)
Figure AFFiRiS AG Multiple System Atrophy Therapeutics Revenue Market Share in United States (2012-2017)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc Multiple System Atrophy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Multiple System Atrophy Therapeutics Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc Multiple System Atrophy Therapeutics Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc Multiple System Atrophy Therapeutics Revenue Market Share in United States (2012-2017)
Table Corestem Inc Basic Information List
Table Corestem Inc Multiple System Atrophy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Corestem Inc Multiple System Atrophy Therapeutics Sales Growth Rate (2012-2017)
Figure Corestem Inc Multiple System Atrophy Therapeutics Sales Market Share in United States (2012-2017)
Figure Corestem Inc Multiple System Atrophy Therapeutics Revenue Market Share in United States (2012-2017)
Table MitoDys Therapeutics Ltd Basic Information List
Table MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Sales Growth Rate (2012-2017)
Figure MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Sales Market Share in United States (2012-2017)
Figure MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Revenue Market Share in United States (2012-2017)
Table Modag GmbH Basic Information List
Table Modag GmbH Multiple System Atrophy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Modag GmbH Multiple System Atrophy Therapeutics Sales Growth Rate (2012-2017)
Figure Modag GmbH Multiple System Atrophy Therapeutics Sales Market Share in United States (2012-2017)
Figure Modag GmbH Multiple System Atrophy Therapeutics Revenue Market Share in United States (2012-2017)
Table Neuropore Therapies Inc Basic Information List
Table Neuropore Therapies Inc Multiple System Atrophy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neuropore Therapies Inc Multiple System Atrophy Therapeutics Sales Growth Rate (2012-2017)
Figure Neuropore Therapies Inc Multiple System Atrophy Therapeutics Sales Market Share in United States (2012-2017)
Figure Neuropore Therapies Inc Multiple System Atrophy Therapeutics Revenue Market Share in United States (2012-2017)
Table Prana Biotechnology Ltd Basic Information List
Table Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Sales Growth Rate (2012-2017)
Figure Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Sales Market Share in United States (2012-2017)
Figure Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple System Atrophy Therapeutics
Figure Manufacturing Process Analysis of Multiple System Atrophy Therapeutics
Figure Multiple System Atrophy Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Multiple System Atrophy Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Multiple System Atrophy Therapeutics
Table Distributors/Traders List
Figure United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Multiple System Atrophy Therapeutics Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Multiple System Atrophy Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Multiple System Atrophy Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories